Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma

NCT05874193 is registered in ClinicalTrials.gov with Cristiana Costa Chase, DO as lead sponsor.

NCT NCT05874193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05874193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
Lead sponsor
Cristiana Costa Chase, DO
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2026
Completion date
November 30, 2028
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory multiple myeloma